Expert Video - Why are Native Americans underrepresented in clinical trials?
Dr. Lacey Running Hawk, a family physician from the Standing Rock Lakota people, discusses why Native Americans are not well-represented in lung cancer clinical trials. She describes Native people used as medical test subjects, reform of clinical trials, informed consent and access for Native people, and tailoring lung cancer treatments to the Native community.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Please rate this content:
Animation - Lung Cancer Clinical Trials and Native Americans
Slide Show - Lung Cancer Clinical Trials and Native Americans
1.
How common is lung cancer in Native American communities?
2.
Why are Native Americans underrepresented in clinical trials?
3.
Which Native American traditions need to be considered when taking part in clinical trials?
4.
Can Native American patients enrolled in clinical trials continue to take treatments recommended by traditional healers?
5.
Why is it important for Native Americans to participate in greater numbers in lung cancer clinical trials?
6.
What has your experience been with lung cancer?
7.
What do people in your Native American community think about lung cancer clinical trials?
8.
As a Native American, would you consider taking part in a lung cancer clinical trial? What advice do you have for others?
9.
What are some of the barriers that limit clinical trial participation among Native Americans?
